Cargando…

Comparative efficacy of second-generation androgen receptor inhibitors for treating prostate cancer: A systematic review and network meta-analysis

INTRODUCTION: Second-generation androgen receptor inhibitors (SGARIs), namely enzalutamide, apalutamide, and darolutamide, are good for improving survival outcomes in prostate cancer patients, but some researchers have shown that using SGARIs increases side effects, which complicates clinicians’ cho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xiangyu, Wang, Qihua, Pan, Yang, Wang, Shangren, Li, Yuezheng, Zhang, Hao, Xu, Mingming, Zhou, Hang, Liu, Xiaoqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034066/ https://www.ncbi.nlm.nih.gov/pubmed/36967752 http://dx.doi.org/10.3389/fendo.2023.1134719

Ejemplares similares

Metabolic syndrome-related prognostic index: Predicting biochemical recurrence and differentiating between cold and hot tumors in prostate cancer
por: Ren, Congzhe, et al.
Publicado: (2023)

Identification of bicalutamide resistance-related genes and prognosis prediction in patients with prostate cancer
por: Li, Yuezheng, et al.
Publicado: (2023)

Comparative efficacy of olaparib in combination with or without novel antiandrogens for treating metastatic castration-resistant prostate cancer
por: Chen, Xiangyu, et al.
Publicado: (2023)

The efficacy and adverse events of conventional and second-generation androgen receptor inhibitors for castration-resistant prostate cancer: A network meta-analysis
por: Zhang, Xianlu, et al.
Publicado: (2023)

Identifying hub genes and common biological pathways between COVID-19 and benign prostatic hyperplasia by machine learning algorithms
por: Zhou, Hang, et al.
Publicado: (2023)

Association of serum 25-hydroxyvitamin D with urinary incontinence in elderly men: evidence based on NHANES 2007-2014
por: Liu, Li, et al.
Publicado: (2023)

Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway Inhibitors
por: Wefel, Jeffrey S., et al.
Publicado: (2022)

Immunosuppressive environment in response to androgen deprivation treatment in prostate cancer
por: Qin, Caipeng, et al.
Publicado: (2022)

Whole-gland high-intensity focused ultrasound ablation and transurethral resection of the prostate in the patients with prostate cancer: A systematic review and meta-analysis
por: Pan, Yang, et al.
Publicado: (2022)

Efficacy and safety of bipolar androgen therapy in castration-resistant prostate cancer following abiraterone or enzalutamide resistance: A systematic review
por: You, Xiangyun, et al.
Publicado: (2023)

Non-Genomic Actions of the Androgen Receptor in Prostate Cancer
por: Leung, Jacky K., et al.
Publicado: (2017)

Treatment of nonmetastatic castration-resistant prostate cancer: focus on second-generation androgen receptor inhibitors
por: Saad, Fred, et al.
Publicado: (2021)

Second generation androgen receptor antagonists and challenges in prostate cancer treatment
por: Chen, Yanhua, et al.
Publicado: (2022)

Androgen Receptor-CaMKK2 Axis in Prostate Cancer and Bone Microenvironment
por: Dadwal, Ushashi C., et al.
Publicado: (2018)

Identification and validation of immune and oxidative stress-related diagnostic markers for diabetic nephropathy by WGCNA and machine learning
por: Xu, Mingming, et al.
Publicado: (2023)

Long noncoding RNAs regulated spermatogenesis in varicocele‐induced spermatogenic dysfunction
por: Wang, Shangren, et al.
Publicado: (2022)

Assessment of oligometastasis status of prostate cancer following combined robot-assisted radical prostatectomy and androgen deprivation versus androgen deprivation therapy alone using PSA percentage decline rate
por: Li, Xuwen, et al.
Publicado: (2023)

Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer
por: Harris, Anna E., et al.
Publicado: (2022)

Novel Treatment Strategy Using Second-Generation Androgen Receptor Inhibitors for Non-Metastatic Castration-Resistant Prostate Cancer
por: Chung, Doo Yong, et al.
Publicado: (2021)

Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A systematic review and meta-analysis
por: Chen, Jiuzhou, et al.
Publicado: (2023)

Leiomyoma of the prostate: A case report and systematic review
por: Wang, Shangren, et al.
Publicado: (2022)

Androgens improve ovarian follicle function impaired by glucocorticoids through an androgen-IGF1-FSH synergistic effect
por: Gao, Lingyun, et al.
Publicado: (2022)

Second-Generation Androgen Receptor Antagonists as Hormonal Therapeutics for Three Forms of Prostate Cancer
por: Rajaram, Pravien, et al.
Publicado: (2020)

Androgen Action in the Ovary
por: Franks, Stephen, et al.
Publicado: (2018)

Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer
por: Kregel, Steven, et al.
Publicado: (2016)

The Androgen Receptor in Breast Cancer
por: Giovannelli, Pia, et al.
Publicado: (2018)

Novel Variant of the Androgen Receptor Gene in a Patient With Complete Androgen Insensitivity Syndrome and Polyorchidism
por: Konrade, Ilze, et al.
Publicado: (2019)

Cardiometabolic Complications after Androgen Deprivation Therapy in a Man with Prostate Cancer: Effects of 3 Years Intermittent Testosterone Supplementation
por: Aversa, Antonio, et al.
Publicado: (2012)

Advances in mitochondria-centered mechanism behind the roles of androgens and androgen receptor in the regulation of glucose and lipid metabolism
por: Yin, Lijun, et al.
Publicado: (2023)

Next-generation Sequencing of Advanced Prostate Cancer Treated with Androgen-deprivation Therapy
por: Rajan, Prabhakar, et al.
Publicado: (2014)

Use of PARP inhibitors in prostate cancer: from specific to broader application
por: Zhang, Zhenting, et al.
Publicado: (2023)

Editorial: The Androgen Receptor in Breast Cancer
por: Tesei, Anna, et al.
Publicado: (2021)

The efficacy and safety in radioactive iodine refractory thyroid cancer patients treated with sorafenib
por: Ling, Yuanna, et al.
Publicado: (2023)

Estrogen Receptors Promote Migration, Invasion and Colony Formation of the Androgen-Independent Prostate Cancer Cells PC-3 Through β-Catenin Pathway
por: Lombardi, Ana Paola G., et al.
Publicado: (2020)

Trends in the Use of Second-Generation Androgen Receptor Axis Inhibitors for Metastatic Hormone-Sensitive Prostate Cancer and Clinical Factors Predicting Biological Recurrence
por: Nakane, Keita, et al.
Publicado: (2023)

Androgen Regulation of the Mesocorticolimbic System and Executive Function
por: Tobiansky, Daniel J., et al.
Publicado: (2018)

Androgen-Regulated Cardiac Metabolism in Aging Men
por: Barrientos, Genaro, et al.
Publicado: (2020)

Androgens and Anemia: Current Trends and Future Prospects
por: Al-Sharefi, Ahmed, et al.
Publicado: (2019)

The role of androgens in pressure overload myocardial hypertrophy
por: Schafstedde, Marie, et al.
Publicado: (2023)

Profiles of 5α-Reduced Androgens in Humans and Eels: 5α-Dihydrotestosterone and 11-Ketodihydrotestosterone Are Active Androgens Produced in Eel Gonads
por: Yazawa, Takashi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n56d7n1v9ae9lmoo4irm29nbn4